Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ebselen for Endothelial Dysfunction in Diabetes Mellitus
NCT00762671Phase 3Completed
- Sponsor
- Brigham and Women's Hospital
- Start
- May 1999
- Primary completion
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ebselen in type 1 diabetes mellitus (T1D), type 2 diabetes mellitus (T2DM), sponsored by Brigham and Women's Hospital. Started May 1999; status: completed.
02
Drugs
ebselen
03
Conditions
type 1 diabetes mellitus (T1D)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00762671.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00762671.